Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q1 2026

Procter & Gamble Q1 2026 Results: Net Income $4.73B, Down 0.4% YoY

Procter & Gamble reported net sales of $23.3 billion for the quarter ended September 30, 2026, a 4% increase over the prior year. Net earnings attributable to the company remained stable at $4.7 billion, with diluted earnings per share increasing slightly to $1.97. The company maintained strong cash flow from operations at $5.8 billion and returned $3.8 billion to shareholders through dividends and stock repurchases.

Q1 2026 at a glance · $ million
MetricQ1 2026Q1 2025
Revenue23,276.022,386.0
Net income4,731.04,750.0
EPS (diluted, $ a share)$1.97$1.95

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year-0.4%
Revenue, year on year+4.0%
Operating margin25.5%
Source

10-Q filed with the SEC, NYSE: PG. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Procter & Gamble Co: key numbers

Share price
$173.02Close, Nov 16
Market cap
$401B
Shares outstanding
2.32BLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Soap, Detergents, Cleang Preparations, Perfumes, CosmeticsSIC 2840

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Procter & Gamble Co

All →
5:11 PM ET Form 4
Insider Selling

Procter & Gamble CEO-Baby and Feminine Care El Hak Hesham Abd Sells $379K of Stock

El Hak Hesham Abd, CEO-Baby and Feminine Care, sold 2,250 shares of Procter & Gamble Co at $168.47 a share, worth $379K in total on Nov 12, 2026. Shares held after the trade: 8,968 (-20.1%).

Value
$379K
Shares
2,250
Price
$168.47
Role
CEO-Baby and Feminine Care
Holding change
-20.1%
Trade date
Nov 12, 2026
11:02 AM ET Form 4
Insider Selling

Procter & Gamble CFO Andre Schulten Sells $5.18M of Stock

Andre Schulten, CFO, sold 30,677 shares of Procter & Gamble Co at $169.00 a share, worth $5.18M in total on Nov 5, 2026. Shares held after the trade: 65,618 (-31.9%).

Value
$5.18M
Shares
30,677
Price
$169.00
Role
CFO
Holding change
-31.9%
Trade date
Nov 5, 2026
11:01 AM ET Form 4
Insider Selling

Procter & Gamble CEO - Grooming de Azevedo Juliana Monteiro Santos Sells $908K of Stock

de Azevedo Juliana Monteiro Santos, CEO - Grooming, sold 5,370 shares of Procter & Gamble Co at $169.00 a share, worth $908K in total on Nov 5, 2026. Shares held after the trade: 21,361 (-20.1%).

Value
$908K
Shares
5,370
Price
$169.00
Role
CEO - Grooming
Holding change
-20.1%
Trade date
Nov 5, 2026
4:42 PM ET 8-K
Loan & Debt

Procter & Gamble Debt Financing Update

The Procter & Gamble Company closed an underwritten public offering of four tranches of Euro-denominated notes totaling €3.25 billion in aggregate principal amount. The offering includes notes maturing in 2030, 2034, 2038, and 2046 with interest rates ranging from 3.750% to 4.625%.

Term
Through Nov 2046
1:02 PM ET Form 4
Insider Selling

Procter & Gamble SVP - CAO Matthew W. Janzaruk Sells $1.55M of Stock

Matthew W. Janzaruk, SVP - CAO, sold 9,479 shares of Procter & Gamble Co at $163.00 a share, worth $1.55M in total on Nov 3, 2026. Shares held after the trade: 1,271 (-88.2%).

Value
$1.55M
Shares
9,479
Price
$163.00
Role
SVP - CAO
Holding change
-88.2%
Trade date
Nov 3, 2026
10:31 AM ET Form 4
Insider Selling

Procter & Gamble CEO- Health Care Paul Gama Sells $478K of Stock

Paul Gama, CEO- Health Care, sold 2,894 shares of Procter & Gamble Co at $165.00 a share, worth $478K in total on Oct 30, 2026. Shares held after the trade: 43,899 (-6.2%).

Value
$478K
Shares
2,894
Price
$165.00
Role
CEO- Health Care
Holding change
-6.2%
Trade date
Oct 30, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.